Acid reflux drugs linked to increased stomach cancer risk
Conclusion
PPIs are commonly used medicines for acid reflux. This may seem like alarming news for the many people in the UK who take them, but it's important to remember that the overall risk of stomach cancer is still very low.
This study has several limitations that mean we should be cautious about the results:
This type of study can't prove PPIs caused the increased risk of cancer. The increased risk could be down to other factors.
Researchers were unable to adjust their figures to take account of some relevant confounding factors, such as alcohol and tobacco use, as these weren't routinely recorded.
Almost all the pati...
Source: NHS News Feed - November 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news
Acid reflux pills 'raise risk of cancer by eight-fold'
Scientists say people who regularly use proton pump inhibitors (PPIs) – common drugs used to treat acid reflux – are twice as likely to develop the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2017 Category: Consumer Health News Source Type: news
PPI Use After H. pylori Eradication Therapy Tied to Increased Risk for Gastric Cancer (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Long-term use of proton-pump inhibitors (PPIs) after treatment for Helicobacter pylori infection is associated with increased risk for gastric cancer, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 1, 2017 Category: Primary Care Source Type: news
Long-term use of PPIs linked to doubling in stomach cancer risk
Risk rose with dose and duration of treatment after H pylori eradication Related items fromOnMedica Proton pump inhibitors associated with raised mortality Oesophageal and stomach cancer linked to early adulthood overweight Experts link alcohol to stomach cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news
Acid reflux drug linked to more than doubled risk of stomach cancer – study
There are more than 50m prescriptions for proton pump inhibitors in the UK, though they have previously been linked to side-effects and increased risk of deathA drug commonly used to treat acid reflux is linked to a more than doubled risk of developing stomach cancer, researchers have claimed.Proton pump inhibitors (PPIs) reduce the amount of acid made by the stomach and are used to treat acid reflux and stomach ulcers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 31, 2017 Category: Science Authors: Press Association Tags: Drugs Cancer Health Society Science Source Type: news
Gastric Cancer Risk Doubled With Long-term PPI Use Gastric Cancer Risk Doubled With Long-term PPI Use
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Long-term PPI Use Tied to Doubled Risk for Gastric Cancer Long-term PPI Use Tied to Doubled Risk for Gastric Cancer
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Are Some Heartburn Meds Tied to Stomach Cancer?
TUESDAY, Oct. 31, 2017 -- Popping certain heartburn drugs like they ' re candy might up your odds for stomach cancer, new research suggests.
The risk was proportionate to how long and how often these drugs, called proton pump inhibitors (PPIs), were... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2017 Category: General Medicine Source Type: news
New Guidelines Support Deprescribing of Proton Pump Inhibitors
Deprescribing proton pump inhibitors (PPIs) in asymptomatic patients who do not truly need treatment can be accomplished through reductions in both dosage and dosing frequency, David S. H. Lee, PharmD, PhD, said at the annual meeting of the American Geriatrics Society in May 2017. (Source: Caring for the Ages)
Source: Caring for the Ages - October 28, 2017 Category: Health Management Authors: Christine Kilgore Source Type: news
PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk? PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk?
New research suggests that reducing patent foramen ovale size could lessen stroke risk, while other work explores the role that PPIs might play in causing dementia.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news
Child Proton Pump Inhibitor Use May Increase Asthma Risk
Risk increased across all age groups with highest risk for infants and toddlers; risk seen across individual PPIs (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Family Medicine, Gastroenterology, Nursing, Pediatrics, Pharmacy, Pulmonology, Allergy, Emergency Medicine, Journal, Source Type: news
PPIs vs. NSAIDs
Title: PPIs vs. NSAIDsCategory: MedicationsCreated: 10/12/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 12, 2017 Category: Drugs & Pharmacology Source Type: news
Study finds no evidence linking reflux medicines to bone fractures
A new study in Alimentary Pharmacology& Therapeutics reports that proton pump inhibitors (PPIs) are not linked to an increased risk of bone fractures or bone thinning, as it was previously believed.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 10, 2017 Category: Endocrinology Source Type: news
Common acid reflux medications promote chronic liver disease
(University of California - San Diego) Approximately 10 percent of Americans take a proton pump inhibitor drug to relieve symptoms of frequent heartburn and acid reflux. That percentage can be much higher for people with chronic liver disease. Researchers at University of California San Diego School of Medicine have discovered evidence in mice and humans that these medications alter gut bacteria in a way that promotes three types of chronic liver disease. The study is published Oct. 10 in Nature Communications. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 10, 2017 Category: International Medicine & Public Health Source Type: news
Woman cured of acid reflux that left her unable to swallow
EXCLUSIVE: Anna Lavinas, from Croydon, struggled with her heartburn ever since childhood. Drugs designed to help combat her reflux, known as PPIs, all failed. (Source: the Mail online | Health)
Source: the Mail online | Health - September 14, 2017 Category: Consumer Health News Source Type: news
